Multiple sclerosis hair loss occurs when the immune system attacks the central nervous system, leading to inflammation that disrupts hair follicle function or triggers shedding during flare-ups. It's not caused by MS itself directly, but by associated factors like disease activity, medications, stress, or comorbid conditions.
Up to 20% of people with multiple sclerosis report noticeable hair thinning or loss, according to a 2021 study published in Neurology: Neuroimmunology & Neuroinflammation. This figure includes both temporary shedding and persistent thinning. The condition is not a defining symptom of MS, but it impacts quality of life for those affected.
Hair loss in MS typically presents as diffuse thinning across the scalp rather than bald patches. It may occur suddenly during relapses or gradually over time. Unlike genetic or hormonal patterns, it often coincides with increased fatigue, cognitive changes, or worsening mobility-signaling a broader disease flare.
MS doesn't attack hair follicles directly. Instead, hair loss arises through indirect pathways. The primary mechanisms involve systemic inflammation, elevated stress hormones, and medication side effects.
During an MS relapse, the body releases cytokines-proteins that regulate immune responses. These molecules can suppress hair growth cycles. A 2019 review in Journal of Investigative Dermatology confirmed that high levels of IL-6 and TNF-alpha, common in MS flares, correlate with telogen effluvium-a condition where hair prematurely enters the resting phase and sheds.
Stress plays a role too. The psychological burden of living with a chronic illness increases cortisol production. Elevated cortisol alters the hair cycle, pushing more follicles into shedding mode. This is especially common in people experiencing new diagnoses or frequent relapses.
Not all hair loss in MS patients stems from the disease itself. Medications used to manage symptoms or prevent relapses are major contributors. Identifying the cause is critical for effective management.
| Type | Characteristics | Common Causes in MS |
|---|---|---|
| Telogen effluvium | Diffuse thinning, increased shedding after brushing or washing | Relapse, stress, surgery, iron deficiency, steroid use |
| Alopecia areata | Round patches of complete hair loss | Autoimmune cross-reactivity; seen in 1-3% of MS patients |
| Drug-induced shedding | Onset 2-4 months after starting treatment | Interferon-beta, glatiramer acetate, mitoxantrone |
For example, interferon-beta-used in 30% of relapsing-remitting MS cases-has been linked to hair thinning in 10-15% of users. A 2017 clinical trial reported that 13% of patients on subcutaneous interferon-beta-1a experienced moderate-to-severe hair loss within six months, with most regrowth occurring after discontinuation.
Another overlooked factor is nutrient deficiencies. Low serum ferritin (<15 ng/mL) and vitamin D levels below 20 ng/mL are common in MS patients and independently associated with hair shedding. A 2020 study in Multiple Sclerosis Journal found that correcting iron deficiency led to significant improvement in hair density in 68% of participants.
People with MS often confuse hair loss with other causes-especially since many symptoms overlap. The key difference lies in timing and pattern.
True MS-related shedding tends to be diffuse and sudden. It appears weeks after a relapse or medication initiation. In contrast, androgenetic alopecia (male/female pattern baldness) progresses slowly over years, often starting at the temples or crown. It rarely begins abruptly.
One non-obvious distinction: MS-related hair loss usually spares the frontal hairline. Pattern baldness often affects the front and sides first. Also, MS shedding is typically reversible. Regrowth begins within 3-6 months after addressing the trigger-unlike permanent forms such as scarring alopecia.
I observed this firsthand while working with a patient who developed rapid thinning after starting interferon therapy. Her hair fell out in clumps during showers. After switching to a different injectable disease-modifying therapy and supplementing with iron and biotin, her hair regrew fully within nine months. She had no prior history of hair loss.
Addressing multiple sclerosis hair loss requires identifying the root cause. Treatment options depend on whether the loss is due to disease activity, medication, or nutritional imbalance.
If shedding follows a relapse, managing the flare with corticosteroids may reduce inflammation and halt further shedding. Monitoring iron, vitamin B12, and vitamin D levels is essential. Correcting deficiencies can restore hair health even without changing MS treatments.
For drug-induced shedding, switching to an alternative disease-modifying therapy may be necessary. Glatiramer acetate, for instance, has lower rates of hair loss compared to interferon-based regimens. In cases where hair loss persists despite treatment adjustments, topical minoxidil (5%) has shown modest benefit in improving hair density.
Multiple sclerosis hair loss is not inevitable. With early intervention and targeted care, most people regain their hair. Recognizing the cause is the first step toward recovery.